Close
Show

Industry Updates

We work to enhance the visibility of our clients through various online marketing & promotional activities like suppliers profile, whitepapers, webinars, online audio & video media presentations.

Our strength lies in our phenomenal services of Targeted Marketing & Behavioral Targeting (e-mail marketing) and providing regular updates about our clients – through pressrelease & monthly e-newsletters support to fill the frequency gap.The service we provide builds an advanced arena to allow our clients to reach both ends of the healthcare facility procurement chain.

CyberKnife System Achieves 38 Percent growth in Extracranial Treatments during Fiscal Year 2008

Accuray Incorporated , a global leader in the field of radiosurgery, announced  that treatments of extracranial tumors using the CyberKnife® Robotic Radiosurgery System increased...

Boston Scientific’s Carotid Artery Stent approved by FDA

Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved its Carotid WALLSTENT® Monorail® Endoprosthesis for the treatment of patients...

Medtronic Launches New Medical Device that Improves Minimally-Invasive Treatment

Extending an unmatched record of innovation in the field of endovascular aortic repair, Medtronic (, Inc., today announced the U.S. market launch of the...

Lee Memorial Health System to Install Agfa HealthCare’s Integrated IMPAX® Radiology &Cardiology PACS

Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, announces today that the Lee Memorial Health System (LMHS) of Southwest...

Elekta announces installation of Leksell Gamma Knife Perfexion at Haukeland University Hospital in N

Leksell Gamma Knife® Perfexion™ is the latest and most advanced solution on the market for non-invasive treatment of brain disorders. This new generation Leksell...

Philips Celsion announce agreement to cancer treatment has ultrasound, drug delivery technology

Royal Philips Electronics and Celsion Corporation announced the signing of a joint research agreement focusing on a new cancer treatment that combines Philips’ ultrasound...

Integra LifeSciences launches accel Evo3, the next generation accell technology

Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has received 510(k) clearance from the United States Food and Drug Administration to market Accell...

New data shows Abbott’s Bioabsorbable Drug Eluting Stent is absorbed within two years

Abbott announced two-year data from 30 patients in its ABSORB clinical trial, demonstrating that its bioabsorbable drug eluting stent successfully treated coronary artery disease...

Siemens Molecular CT Takes the Lead in the Evolution of Diagnostic Imaging

Continuing its leadership in molecular imaging innovation, Siemens Healthcare (www.siemens.com/healthcare) introduces Biograph mCT at the European Association of Nuclear Medicine conference in Munich, Germany....

Medtronic’s Third-Generation Endeavor® Resolute Drug-Eluting Stent Maintains Strong Efficacy and Saf

Of those treated with the Endeavor® Resolute drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), in the RESOLUTE IDE trial only two patients required...